V25-S1 Vascular Access Guidelines
$15.00
Related products
-
V29-4 Health Disparities and Outcomes in Canadian Indigenous End-Stage Kidney Disease Patients
$15.00 Add to cart -
V29-3 Potassium Binding Agents: Patiromer and Sodium Zirconium Cycloscilicate
$15.00 Add to cart -
V30-1 Hypoxia-inducible factor (HIF) stabilizers: An emerging treatment option for anemia in chronic kidney disease
$15.00 Add to cart -
V29-2 Prevention and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease
$15.00 Add to cart